Free Trial
NASDAQ:NTHI

Neonc Technologies (NTHI) Stock Price, News & Analysis

Neonc Technologies logo
$7.41 +0.19 (+2.63%)
As of 05/27/2025 04:00 PM Eastern

About Neonc Technologies Stock (NASDAQ:NTHI)

Key Stats

Today's Range
$7.00
$7.57
50-Day Range
$4.36
$16.55
52-Week Range
$4.11
$25.00
Volume
60,917 shs
Average Volume
82,334 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Receive NTHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neonc Technologies and its competitors with MarketBeat's FREE daily newsletter.

NTHI Stock News Headlines

Trump Quietly Planning $15 Trillion Crypto Shocker
Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.
NeOnc Technologies announces global patent portfolio totals 176
See More Headlines

NTHI Stock Analysis - Frequently Asked Questions

Neonc Technologies' stock was trading at $12.00 on January 1st, 2025. Since then, NTHI stock has decreased by 38.3% and is now trading at $7.41.
View the best growth stocks for 2025 here
.

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) issued its earnings results on Friday, May, 9th. The company reported ($2.10) earnings per share (EPS) for the quarter. The firm had revenue of $0.04 million for the quarter.

Neonc Technologies (NTHI) raised $52 million in an IPO on Wednesday, March 26th 2025. The company issued 2,100,000 shares at $25.00 per share. RBW Capital Partners (Division of Dawson James) acted as the underwriter for the IPO.

Neonc Technologies' top institutional shareholders include HighPoint Advisor Group LLC and Royal Bank of Canada. Insiders that own company stock include Amir F Heshmatpour, Thomas C Chen, Keithly Garnett and Jim Delshad.
View institutional ownership trends
.

Shares of NTHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/09/2025
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NTHI
Previous Symbol
NASDAQ:NTHI
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$79,990.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:NTHI) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners